Molecular imaging of photodynamic therapy

Recent advances in light sources, detectors and other optical imaging technologies coupled with the development of novel optical contrast agents have enabled real-time, high resolution, in vivo monitoring of molecular targets. Noninvasive monitoring of molecular targets is particularly relevant to photodynamic therapy (PDT), including the delivery of photosensitizer in the treatment site and monitoring of molecular and physiological changes following treatment. Our lab has developed optical imaging technologies to investigate these various aspects of photodynamic therapy (PDT). We used a laser scanning confocal microscope to monitor the pharmacokinetics of various photosensitizers in in vitro as well as ex vivo samples, and developed an intravital fluorescence microscope to monitor photosensitizer delivery in vivo in small animals. A molecular specific contrast agent that targets the vascular endothelial growth factor (VEGF) was developed to monitor the changes in the protein expression following PDT. We were then able to study the physiological changes due to post-treatment VEGF upregulation by quantifying vascular permeability with in vivo imaging.

[1]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[2]  Stephen G Bown,et al.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. , 2002, The Journal of urology.

[3]  T. Wieman,et al.  Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville. , 2000, In vivo.

[4]  Fan Zhang,et al.  Angiogenesis Induced by Photodynamic Therapy in Normal Rat Brain¶ , 2004, Photochemistry and photobiology.

[5]  K. Sano,et al.  Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy. , 2001, European journal of cancer.

[6]  T. Hasan,et al.  Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells , 2002, British Journal of Cancer.

[7]  C J Gomer,et al.  Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. , 2000, Cancer research.

[8]  R. Jain,et al.  Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.

[9]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[10]  S. Andersson,et al.  Photodynamic therapy of localised prostatic cancer , 1990, The Lancet.

[11]  R. Jain,et al.  Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. , 2001, Cancer research.

[12]  C. Dinney,et al.  Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  Peter K. Kik,et al.  Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD) , 1999, British Journal of Cancer.

[14]  D. Kessel,et al.  Localization and Photodynamic Efficacy of Two Cationic Porphyrins Varying in Charge Distribution¶ , 2003 .

[15]  R. Weichselbaum,et al.  Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. , 1999, Cancer research.

[16]  R K Jain,et al.  Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. , 1999, Cancer research.

[17]  A. Levine,et al.  Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line , 2004, Clinical & Experimental Metastasis.

[18]  T. Stokke,et al.  Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light , 1999, British Journal of Cancer.

[19]  K. Camphausen,et al.  Radiation therapy to a primary tumor accelerates metastatic growth in mice. , 2001, Cancer research.

[20]  Michael R Hamblin,et al.  Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. , 1998, Cancer research.

[21]  R. Weichselbaum,et al.  Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation , 1999 .

[22]  D. Kessel,et al.  Localization and Photodynamic Efficacy of Two Cationic Porphyrins Varying in Charge Distribution ¶ , 2003, Photochemistry and photobiology.

[23]  Jamal Zweit,et al.  Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. , 2002, Journal of the National Cancer Institute.

[24]  F. Hetzel,et al.  Tumor Oxygenation Changes Post‐Photodynamic Therapy , 1996, Photochemistry and photobiology.